» Articles » PMID: 25881087

"Why Should I Take Drugs for Your Infection?": Outcomes of Formative Research on the Use of HIV Pre-exposure Prophylaxis in Nigeria

Overview
Publisher Biomed Central
Specialty Public Health
Date 2015 Apr 17
PMID 25881087
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nigeria has the second highest number of new HIV infections annually. Therefore, it is important to explore new strategies for preventing new infections. The introduction of pre-exposure prophylaxis (PrEP) for use by persons at high risk of HIV infection has new potential in preventing new HIV infections. The aim of this study is to explore the public opinion, community interest, and perceptions about the use and access to PrEP in Nigeria.

Methods: This formative study used a mixed method approach to collect data on public opinions and perceptions on appropriate target groups for PrEP access, community interest, perceptions about the use of PrEP as an HIV-prevention tool, how best to communicate with participants about PrEP, concerns about PrEP use by serodiscordant couples, and suggestions for the design and implementation of a PrEP demonstration project. Telephone and in-depth interviews were conducted, and focus group discussions and consultative meetings were held with critical stakeholders engaged in HIV-prevention, treatment, care, and support programmes in Nigeria. An online survey was also conducted.

Results: HIV serodiscordant couples were identified as the appropriate target group for PrEP use. Most respondents felt that PrEP use by key affected populations would help reduce the HIV incidence. Stigma was identified as a major concern and a potential barrier for the acceptance and use of PrEP by HIV serodiscordant couples. Electronic and print media were identified as important means for massive public education to prevent stigma and create awareness about PrEP. In a male dominated society such as Nigeria, HIV-negative male partners in serodiscordant relationships may resist enrolment in PrEP programmes. This may be complicated by the fact that the identified index partner in most serodiscordant relationships in Nigeria is an HIV-positive woman, who is often diagnosed during pregnancy.

Conclusions: PrEP uptake and use by HIV serodiscordant couples in Nigeria may face notable but surmountable challenges. Much depends on the appropriateness of actions taken by multiple players. Motivation of HIV-negative male partners to use PrEP and establishment of effective public education programmes in addressing stigma are essential.

Citing Articles

Assessing awareness and utilisation of pre-exposure prophylaxis for HIV prevention among women who inject drugs in Lagos, Nigeria: a cross-sectional study.

Onigbogi O, Eghaghe O, Onigbogi M, Ojo O, Babalola O BMJ Public Health. 2025; 2(1):e000293.

PMID: 40018130 PMC: 11812754. DOI: 10.1136/bmjph-2023-000293.


Hoping to Adhere? Examining the Relationship Between Hope and Pre-exposure Prophylaxis Willingness, Adherence, and Persistence Among Young Women in South Africa and Zimbabwe (HPTN 082).

Gichane M, Velloza J, Hosek S, Beauchamp G, Anderson P, Delany-Moretlwe S AIDS Behav. 2024; 29(2):527-534.

PMID: 39446266 PMC: 11814051. DOI: 10.1007/s10461-024-04536-3.


Awareness of, willingness to use, and experiences with Pre-exposure prophylaxis among youth in Nigeria.

Gbaja-Biamila T, Obiezu-Umeh C, Nwaozuru U, Rosenberg N, Igbokwe M, Oladele D BMC Health Serv Res. 2024; 24(1):1128.

PMID: 39334111 PMC: 11428911. DOI: 10.1186/s12913-024-11459-1.


Effectiveness of three delivery models for promoting access to pre-exposure prophylaxis in HIV-1 serodiscordant couples in Nigeria.

Folayan M, Aliyu S, Oginni A, Ezechi O, Kolawole G, Ezeama N PLoS One. 2022; 17(5):e0268011.

PMID: 35511948 PMC: 9070899. DOI: 10.1371/journal.pone.0268011.


The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.

Velloza J, Khoza N, Scorgie F, Chitukuta M, Mutero P, Mutiti K J Int AIDS Soc. 2020; 23(3):e25463.

PMID: 32144874 PMC: 7060297. DOI: 10.1002/jia2.25463.


References
1.
Eluwa G, Strathdee S, Adebayo S, Ahonsi B, Adebajo S . A profile on HIV prevalence and risk behaviors among injecting drug users in Nigeria: should we be alarmed?. Drug Alcohol Depend. 2012; 127(1-3):65-71. DOI: 10.1016/j.drugalcdep.2012.06.013. View

2.
Kitara D, Aloyo J . HIV/AIDS Stigmatization, the Reason for Poor Access to HIV Counseling and Testing (HCT) Among the Youths in Gulu (Uganda). Afr J Infect Dis. 2013; 6(1):12-20. PMC: 3555436. DOI: 10.4314/ajid.v6i1.77737. View

3.
Sagay A, Onakewhor J, Galadanci H, Emuveyan E . HIV status of partners of HIV positive pregnant women in different regions of Nigeria: matters arising. Afr J Med Med Sci. 2007; 35 Suppl:125-9. View

4.
Latkin C, Knowlton A . Micro-social structural approaches to HIV prevention: a social ecological perspective. AIDS Care. 2005; 17 Suppl 1:S102-13. DOI: 10.1080/09540120500121185. View

5.
Ikechebelu J, Mbamara S, Joe-Ikechebebelu N, Ezenwabachili A . Sexual practices of people living with HIV in South Eastern Nigeria. Niger J Clin Pract. 2010; 12(4):416-20. View